Lv4
610 积分 2023-03-03 加入
Bispecific and multispecific antibodies in oncology: opportunities and challenges
3天前
已完结
Publisher Correction: Role of thymic stromal lymphopoietin in allergy and beyond
19天前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
19天前
已完结
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
2个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
6个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
6个月前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
6个月前
已完结
The antibody–drug conjugate landscape
6个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8个月前
已完结
Design, Synthesis, In Vitro and In Vivo Evaluation of Cereblon Binding Bruton’s Tyrosine Kinase (BTK) Degrader CD79b targeted Antibody Drug Conjugates
8个月前
已完结
皖公网安备34019202002308
